Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in developing novel therapeutic strategies for Alzheimer’s disease
Jiqing Cao, Jianwei Hou, Jing Ping, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 237

Showing 26-50 of 237 citing articles:

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside
Fahadul Islam, Mohamed H. Nafady, Md. Rezaul Islam, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4384-4404
Closed Access | Times Cited: 58
Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism
Laura Bonfili, Massimiliano Cuccioloni, Chunmei Gong, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 3, pp. 698-708
Open Access | Times Cited: 45
Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials
Tanzeel Khan, Rashid Waseem, Mohammad Shahid, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102113-102113
Closed Access | Times Cited: 28
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 27
Systematic comparison of 3D Deep learning and classical machine learning explanations for Alzheimer’s Disease detection
Louise Bloch, Christoph M. Friedrich
Computers in Biology and Medicine (2024) Vol. 170, pp. 108029-108029
Open Access | Times Cited: 9
TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis
Yonglin Liu, Xi Xu, Xiao-Ming Wu, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 74-74
Open Access | Times Cited: 1
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications
Ahmed Sayed, Eshak I. Bahbah, Serageldin Kamel, et al.
Journal of Neuroimmunology (2020) Vol. 349, pp. 577398-577398
Closed Access | Times Cited: 69
Research Progress on Alzheimer's Disease and Resveratrol
Yan Yan, Huihuang Yang, Yuxun Xie, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 989-1006
Closed Access | Times Cited: 68
Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer’s disease
Fange Kong, Xue Jiang, Ruochen Wang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 68
MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s disease pathogenesis
Jiqing Cao, Min Huang, Lei Guo, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 4687-4701
Open Access | Times Cited: 57
Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer's disease
Wenrui Qu, Baoming Yuan, Jun Liu, et al.
Cell Proliferation (2020) Vol. 54, Iss. 1
Open Access | Times Cited: 54
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 53
Aging biomarkers and the brain
Albert Higgins‐Chen, Kyra Thrush, Morgan E. Levine
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 180-193
Open Access | Times Cited: 52
Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models
Ming Chen, Yunan Chen, Qingwei Huo, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 50
Effect of alcohol on the central nervous system to develop neurological disorder: pathophysiological and lifestyle modulation can be potential therapeutic options for alcohol-induced neurotoxication
Zinia Pervin, Julia M. Stephen
AIMS neuroscience (2021) Vol. 8, Iss. 3, pp. 390-413
Open Access | Times Cited: 49
Data analysis with Shapley values for automatic subject selection in Alzheimer’s disease data sets using interpretable machine learning
Louise Bloch, Christoph M. Friedrich
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease
Tahir Ali, Shafiq Ur Rehman, Amjad Khan, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 47
Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology
Bibin G. Anand, Qi Wu, Maryam Nakhaei‐Nejad, et al.
Bioactive Materials (2022) Vol. 17, pp. 506-525
Open Access | Times Cited: 38
Coumarins from Rutaceae: Chemical diversity and biological activities
Cezar Miguel Santos, Samara Machado Cardoso Silva, Edijane Matos Sales, et al.
Fitoterapia (2023) Vol. 168, pp. 105489-105489
Closed Access | Times Cited: 17
Methods and clinical biomarker discovery for targeted proteomics using Olink technology
Han Wang, Tian Zhao, Jingjing Zeng, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 5
Closed Access | Times Cited: 8
Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges
Annalucia Serafino, Daniela Giovannini, Simona Rossi, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 7, pp. 803-822
Closed Access | Times Cited: 48
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1565-1581
Open Access | Times Cited: 40
The bioactivity of benzenesulfonyl hydrazones: A short review
Łukasz Popiołek
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111851-111851
Open Access | Times Cited: 40
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1126-1126
Open Access | Times Cited: 39
Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl
Li‐Feng‐Rong Qi, Shuai Liu, Yu-Ci Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5559-5559
Open Access | Times Cited: 38

Scroll to top